skip to main content
Idioma:
Primo Search
Clear Search Box
Search in: Busca Geral
Busca Avançada
Busca por Índices

Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells

de Soure, António M. ; Fernandes-Platzgummer, Ana ; da Silva, Cláudia L. ; Cabral, Joaquim M.S.

Journal of biotechnology, 2016-10, Vol.236, p.88-109 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
  • Título:
    Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells
  • Autor: de Soure, António M. ; Fernandes-Platzgummer, Ana ; da Silva, Cláudia L. ; Cabral, Joaquim M.S.
  • Assuntos: Animals ; Bioreactors ; Cell Culture Techniques ; Cell manufacturing ; Cells, Cultured ; Ex vivo expansion ; Humans ; Mesenchymal stem/stromal cells ; Mesenchymal Stromal Cells ; Mice ; Microcarriers ; Serum/xenogeneic-free
  • É parte de: Journal of biotechnology, 2016-10, Vol.236, p.88-109
  • Notas: ObjectType-Article-2
    SourceType-Scholarly Journals-1
    ObjectType-Feature-3
    content type line 23
    ObjectType-Review-1
  • Descrição: •Comprehensive overview on the manufacturing of human mesenchymal stem/stromal cells.•Bioprocess engineering approaches combining bioreactors with microcarrier technology for the expansion of mesenchymal stem/stromal cells.•Current and future mesenchymal stem/stromal cell manufacturing challenges. Due to their unique features, mesenchymal stem/stromal cells (MSC) have been exploited in clinical settings as therapeutic candidates for the treatment of a variety of diseases. However, the success in obtaining clinically-relevant MSC numbers for cell-based therapies is dependent on efficient isolation and ex vivo expansion protocols, able to comply with good manufacturing practices (GMP). In this context, the 2-dimensional static culture systems typically used for the expansion of these cells present several limitations that may lead to reduced cell numbers and compromise cell functions. Furthermore, many studies in the literature report the expansion of MSC using fetal bovine serum (FBS)-supplemented medium, which has been critically rated by regulatory agencies. Alternative platforms for the scalable manufacturing of MSC have been developed, namely using microcarriers in bioreactors, with also a considerable number of studies now reporting the production of MSC using xenogeneic/serum-free medium formulations. In this review we provide a comprehensive overview on the scalable manufacturing of human mesenchymal stem/stromal cells, depicting the various steps involved in the process from cell isolation to ex vivo expansion, using different cell tissue sources and culture medium formulations and exploiting bioprocess engineering tools namely microcarrier technology and bioreactors.
  • Editor: Netherlands: Elsevier B.V
  • Idioma: Inglês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.